S-1/Cisplatin

DRUG4 trials

Sponsors

Taiho Oncology, Inc., Seoul National University Hospital

Conditions

Gastric CancerImpaired Hepatic FunctionRenal Impairment

Phase 1

Evaluating Patients With Varying Degrees of Renal Function

CompletedNCT00398307

Taiho Oncology, Inc.Renal Impairment

Start: 2006-02-28End: 2010-09-30Target: 24Updated: 2024-09-05

Evaluating Patients With Impaired Hepatic Function

CompletedNCT00398424

Taiho Oncology, Inc.Impaired Hepatic Function

Start: 2006-02-28End: 2009-03-31Target: 24Updated: 2024-09-03

Phase 3

A Safety and Efficacy Study in Patients With Gastric Cancer

CompletedNCT00400179

Taiho Oncology, Inc.Gastric Cancer

Start: 2005-05-31End: 2008-04-30Updated: 2024-09-19

Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer

CompletedNCT02114359

Seoul National University HospitalGastric Cancer

Start: 2014-02-28End: 2020-02-29Updated: 2020-10-23

Related Papers

Identification of patient population with longer survival when treated with S-1 plus cisplatin via predictive enrichment strategy analysis of the FLAGS phase III trial.

Journal of Clinical Oncology2017-05-201 citations